259 related articles for article (PubMed ID: 20576731)
1. Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD.
Daniels JM; Schoorl M; Snijders D; Knol DL; Lutter R; Jansen HM; Boersma WG
Chest; 2010 Nov; 138(5):1108-15. PubMed ID: 20576731
[TBL] [Abstract][Full Text] [Related]
2. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
[TBL] [Abstract][Full Text] [Related]
3. Influence of steroids on procalcitonin and C-reactive protein in patients with COPD and community-acquired pneumonia.
Perren A; Cerutti B; Lepori M; Senn V; Capelli B; Duchini F; Domenighetti G
Infection; 2008 Mar; 36(2):163-6. PubMed ID: 18330505
[TBL] [Abstract][Full Text] [Related]
4. Acute exacerbations of chronic obstructive pulmonary disease with low serum procalcitonin values do not benefit from antibiotic treatment: a prospective randomized controlled trial.
Wang JX; Zhang SM; Li XH; Zhang Y; Xu ZY; Cao B
Int J Infect Dis; 2016 Jul; 48():40-5. PubMed ID: 27155210
[TBL] [Abstract][Full Text] [Related]
5. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease.
Lacoma A; Prat C; Andreo F; Lores L; Ruiz-Manzano J; Ausina V; Domínguez J
Int J Chron Obstruct Pulmon Dis; 2011; 6():157-69. PubMed ID: 21468168
[TBL] [Abstract][Full Text] [Related]
6. Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD.
Stolz D; Christ-Crain M; Morgenthaler NG; Leuppi J; Miedinger D; Bingisser R; Müller C; Struck J; Müller B; Tamm M
Chest; 2007 Apr; 131(4):1058-67. PubMed ID: 17426210
[TBL] [Abstract][Full Text] [Related]
7. Detection of acute phase response and infection. The role of procalcitonin and C-reactive protein.
Rothenburger M; Markewitz A; Lenz T; Kaulbach HG; Marohl K; Kuhlmann WD; Weinhold C
Clin Chem Lab Med; 1999 Mar; 37(3):275-9. PubMed ID: 10353472
[TBL] [Abstract][Full Text] [Related]
8. Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD.
Bafadhel M; Clark TW; Reid C; Medina MJ; Batham S; Barer MR; Nicholson KG; Brightling CE
Chest; 2011 Jun; 139(6):1410-1418. PubMed ID: 21030489
[TBL] [Abstract][Full Text] [Related]
9. Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study.
Daubin C; Parienti JJ; Vabret A; Ramakers M; Fradin S; Terzi N; Freymuth F; Charbonneau P; du Cheyron D
BMC Infect Dis; 2008 Oct; 8():145. PubMed ID: 18947382
[TBL] [Abstract][Full Text] [Related]
10. Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.
Chang CH; Tsao KC; Hu HC; Huang CC; Kao KC; Chen NH; Yang CT; Tsai YH; Hsieh MJ
Int J Chron Obstruct Pulmon Dis; 2015; 10():767-74. PubMed ID: 25926728
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and Prognostic Value of Inflammatory Parameters Including Neopterin in the Setting of Pneumonia, COPD, and Acute Exacerbations.
Pizzini A; Lunger F; Sahanic A; Nemati N; Fuchs D; Weiss G; Kurz K; Bellmann-Weiler R
COPD; 2017 Jun; 14(3):298-303. PubMed ID: 28548632
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil CD64 as a Marker of Bacterial Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Qian W; Huang GZ
Immunol Invest; 2016 Aug; 45(6):490-503. PubMed ID: 27224474
[TBL] [Abstract][Full Text] [Related]
13. Procalcitonin and C-reactive protein in infective endocarditis: correlation with etiology and prognosis.
Kocazeybek B; Küçükoğlu S; Oner YA
Chemotherapy; 2003 May; 49(1-2):76-84. PubMed ID: 12714816
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of Procalcitonin, C-Reactive Protein, and Interleukin-6 in Helping Guide the Antibiotic Use for Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Song W; Wang Y; Tian F; Ge L; Shang X; Zeng Q; Feng N; Fan J; Wang J; Ma X
Dis Markers; 2021; 2021():8879401. PubMed ID: 33791046
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.
Stolz D; Christ-Crain M; Bingisser R; Leuppi J; Miedinger D; Müller C; Huber P; Müller B; Tamm M
Chest; 2007 Jan; 131(1):9-19. PubMed ID: 17218551
[TBL] [Abstract][Full Text] [Related]
16. Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?
Pereira JM; Teixeira-Pinto A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA
J Crit Care; 2013 Dec; 28(6):970-4. PubMed ID: 24216331
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin fails to differentiate inflammatory status or predict long-term outcomes in peritoneal dialysis-associated peritonitis.
Lam MF; Leung JC; Lam CW; Tse KC; Lo WK; Lui SL; Chan TM; Tam S; Lai KN
Perit Dial Int; 2008; 28(4):377-84. PubMed ID: 18556380
[TBL] [Abstract][Full Text] [Related]
18. Serum procalcitonin and C-reactive protein for differentiating bacterial infection from disease activity in patients with systemic lupus erythematosus.
Yu J; Xu B; Huang Y; Zhao J; Wang S; Wang H; Yang N
Mod Rheumatol; 2014 May; 24(3):457-63. PubMed ID: 24252006
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial.
Verduri A; Luppi F; D'Amico R; Balduzzi S; Vicini R; Liverani A; Ruggieri V; Plebani M; Barbaro MP; Spanevello A; Canonica GW; Papi A; Fabbri LM; Beghè B;
PLoS One; 2015; 10(3):e0118241. PubMed ID: 25760346
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic value of C-reactive protein and procalcitonin for bacterial infection in acute exacerbations of chronic obstructive pulmonary disease].
Zhang Y; Zhou L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Sep; 39(9):939-43. PubMed ID: 25269493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]